Original article<br>Favourable prognosis in medulloblastoma with extensive nodularity is associated with mitogen-activated protein kinase upregulation

Jarosław Jóźwiak; Iwona Sontowska; Barbara Bikowska; Wiesława Grajkowska; Ryszard Galus; Marcin Roszkowski

eISSN: 1509-572x
ISSN: 1641-4640

Folia Neuropathologica

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2011
vol. 49

Send email

Copy url:

abstract:

Original article
Favourable prognosis in medulloblastoma with extensive nodularity is associated with mitogen-activated protein kinase upregulation

Jarosław Jóźwiak

,

Iwona Sontowska

,

Barbara Bikowska

,

Wiesława Grajkowska

,

Ryszard Galus

,

Marcin Roszkowski

Folia Neuropathol 2011; 49 (4): 257-261

Online publish date: 2011/12/20

View full text Get citation

Medulloblastoma with extensive nodularity (MBEN) is the only type of medulloblastoma (MB), an aggressive CNS tumour of childhood, that is connected with favourable prognosis. In patients with MBEN tumour resection and chemotherapy are sometimes sufficient. While development of other types of MB is usually connected with activation of the wingless pathway, sonic hedgehog pathway or mammalian target of rapamycin (mTor) pathway, little is known about the molecular basis of MBEN pathophysiology. In the present paper we evaluated activation of the mTor pathway and kinases upstream of mTor, mitogen-activated protein kinase (MAPK/Erk) and protein kinase B (PKB/Akt) in an MBEN sample. Using western blot technique with antibodies directed against active, phosphorylated forms of proteins, we found upregulation of mTor, Akt and Erk. Thus we postulate that the mTor pathway, often implicated in the development of CNS tumours, is also responsible for MBEN progression. Especially interesting seems implication of Erk and other kinases belonging to the same pathway: mitogen-activated protein kinase kinase (MEK-1) or phospho-ribosomal S6 kinase-1 (p90 RSK1), whose activity we usually demonstrate in more benign neoplasms. However, it remains to be clarified whether Erk pathway activation is actually prognostic for benign tumour development.

keywords:

Original articleFavourable prognosis in medulloblastoma with extensive nodularity is associated with mitogen-activated protein kinase upregulation

Jarosław Jóźwiak , Iwona Sontowska , Barbara Bikowska , Wiesława Grajkowska , Ryszard Galus , Marcin Roszkowski

medulloblastoma with extensive nodularity, mTor, mitogen-activated protein kinase

Original article
Favourable prognosis in medulloblastoma with extensive nodularity is associated with mitogen-activated protein kinase upregulation

Jarosław Jóźwiak

,

Iwona Sontowska

,

Barbara Bikowska

,

Wiesława Grajkowska

,

Ryszard Galus

,

Marcin Roszkowski